Home / Business (page 2)

Business

Mazor Robotics Reports Orders for Six Renaissance Systems During the Fourth Quarter of 2014 מזור רובוטיקה מדווחת על הזמנות לשש מערכות רנסנס במהלך הרבעון הרביעי של 2014

Mazor Robotics Ltd., developer of robotic surgical guidance systems, announced that the company received six orders for Renaissance spine surgery systems in fourth quarter 2014. Completion of these agreements did not occur by the end of the year and as a ...

Read More »

RedHill Biopharma Business Outlook and Anticipated Key Milestones for 2015 התחזית העסקית ואבני הדרך הצפוי של רדהיל ביופרמה ב2015

RedHill BioPharma Ltd., a biopharmaceutical company focused on the development and acquisition of late clinical-stage orally administered drugs for treating inflammatory and gastrointestinal diseases, announced selected key milestones and events anticipated in 2015. Upcoming milestones include: Top-line data from ongoing first Phase III study ...

Read More »

Protalix BioTherapeutics Announces New Strategy for Accelerated Growth פרוטליקס מכריז על אסטרטגיה חדשה לצמיחה מואצת

Protalix Biotherapeutics, a biopharmaceutical company focused on developing recombinant therapeutic proteins expressed through its plant cell-based expression system, is prioritizing pipeline candidates to focus on bio-better products with a clear competitive advantage. Therapeutic areas of focus will include Fabry disease, inflammatory bowel disease, ...

Read More »

NeuroDerm Share Prices Soar After Positive Results in Phase IIa Parkinson’s Trial המניה של נוירודרם הוכפל לאור תוצאות ניסוי לטיפול בפרקינסון

Rehovot-based NeuroDerm Ltd. (NASDAQ: NDRM) ended 2014 on a high note as it saw its share price more than double following announcement of positive results in a Phase IIa Parkinson’s drug trial. According to the company, administration of a continuous subcutaneous high-level dose of ...

Read More »

Enzymotec Ltd. Announces an Extraordinary General Meeting of Shareholders אנזימוטק בע"מ מכריז על אסיפה כללית מיוחדת של בעלי מניות

Enzymotec Ltd., an Israel-based global company that modifies lipids harvested from natural sources to develop nutritional ingredients and medical foods, will hold an Extraordinary General Meeting of Shareholders in February. The purpose of the meeting is to elect a director, approve ...

Read More »

Therapix Bio Plans Exclusive License of Anti-CD3 Antibody to Chinese Company תראפיקס ביו מתכנן רישיון בלעדי של נוגדן טיפולי לסין

Therapix Biosciences subsidiary OrImmune Bio has entered into a strategic collaboration with Nanjing BioSciKin Co to discuss an exclusive license to develop, manufacture and commercialize the company’s anti-CD3 antibody in China. As part of the agreement, Nanjing BioSciKin would provide a $300,000 cash ...

Read More »

Compugen Announces Cancer Research Collaboration with Johns Hopkins University קומפיוג'ן הודיעה על שיתוף פעולה עם אוניברסיטת ג'ונס הופקינס במחקר על סרטן

Compugen (NASDAQ:CGEN; TASE:CGEN) has entered into a multi-year research collaboration with Johns Hopkins University School of Medicine to evaluate novel “immune checkpoint” candidates discovered by Compugen for potential treatment of cancer. The research will be directed by Johns Hopkins University’s Prof. Drew Pardoll ...

Read More »

Teva Receives FDA Approval For First Waterless Nasal Aerosol for Allergic Rhinitis In Young Children טבע הודיעה על קבלת אישור לפורמולציה במינון נמוך יותר של תרסיס לאף לילדים

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) has announced that the U.S. Food and Drug Administration (FDA) approved QNASL® (beclomethasone dipropionate) 40 mcg for treatment of seasonal and year-round nasal symptoms associated with allergic rhinitis (AR) in children 4-11 years of age. An ...

Read More »

Bloomberg Philanthropies Announces First International Innovation Teams Grants For Jerusalem And Tel Aviv-Yafo בלומברג פילנתרופיים מכריז על מענקים בינלאומים ראשונים לירושלים ותל אביב-יפו

Bloomberg Philanthropies has announced that Jerusalem and Tel Aviv-Yafo are the first non-U.S. cities selected to take part in the $45 million expansion of its Innovation Teams program. The initiative aims to improve the ability of City Halls to effectively design and carry out new approaches that ...

Read More »

IonMed Plasma Tissue Welding Receives CE Mark Clearance ריתוך הרקמת פלזמה של איונמד בע"מ קיבל אישור באירופה

IonMed announced today that the Yokneam-based company has received CE mark clearance for a cold plasma biowelding device that connects tissues post-surgically, signifying that the product meets EU safety, health and environmental protection requirements. The BioWeld1 system couples a cold plasma jet with a proprietary ...

Read More »